Large Load Customers - Data Centers and Rate Schedule Requirements
Summary
HB1082 establishes a temporary State-Based Health Insurance Subsidies Program within the Maryland Health Benefit Exchange to help individuals buy health benefit plans in the individual market if federal advance premium tax credits are reduced or eliminated. The program is designed to offset higher out-of-pocket premium costs, maintain affordability, and support enrollment in the exchange. It is targeted specifically to calendar years 2026 and 2027, with the program and related funding authority expiring by June 30, 2028 unless earlier terminated by federal action or lack of triggering conditions.
The bill also amends the Maryland Health Benefit Exchange Fund to authorize state money to be used for these new subsidies, alongside existing uses such as exchange operations, reinsurance, health equity resource communities, and the young adult subsidy pilot program. It requires the Exchange, in consultation with the Insurance Commissioner and with board approval, to set eligibility and payment rules, adopt regulations, and track monthly spending, average subsidy amounts, participation, and effects on individual market rates. The Exchange must publish this information and include it in its annual report.
The bill’s practical effect on state law is to create a new contingent subsidy mechanism and expand the permitted uses of the Exchange Fund. It also adjusts the fund’s accounting and spending provisions so that certain state-designated funds can support both the reinsurance program and the new subsidy program. The law is contingent on a federal reduction in advance premium tax credits and a state determination that such a change would raise average net premiums in the individual market by at least 15 percent.
The overall sentiment reflected in the voting history appears supportive, with the bill passing both chambers by substantial margins. No committee transcript excerpts were provided, so there is no recorded floor or committee debate to indicate detailed arguments for or against the measure. The broad bipartisan vote suggests general agreement on the need to protect consumers from a potential federal subsidy reduction.
The main point of contention built into the bill is fiscal and policy prioritization: the Exchange must balance funding for the new subsidies against continued support for the state reinsurance program and other exchange-related obligations. The bill also limits the program to a short window and makes it contingent on federal policy changes, reflecting concern about committing state resources unless a significant premium shock occurs. Stakeholders most directly affected are individual-market enrollees, the Maryland Health Benefit Exchange, insurers offering individual plans, and state budget officials responsible for allocating fund resources.
Impact
HB1082 adds a new Section 31-125 to the Insurance Article and amends Section 31-107 to authorize the Maryland Health Benefit Exchange Fund to finance a State-Based Health Insurance Subsidies Program under specified conditions. It expands the fund’s permissible uses, creates reporting and regulatory duties for the Exchange, and allows state-designated funds to be used to offset premium increases in the individual market. The bill is temporary and contingent, with its operative provisions triggered only if federal advance premium tax credits are reduced or eliminated and the state finds that premiums would rise materially.
Sentiment
The voting history indicates strong support for the bill, with large majorities in both chambers approving it. The absence of committee transcript material limits insight into detailed debate, but the structure of the bill suggests a consensus around protecting affordability in the individual market if federal assistance declines. The measure appears to have been viewed as a precautionary consumer-protection response rather than a permanent expansion of state subsidies.
Contention
The principal policy tension is between using limited state health insurance funds for new subsidies versus preserving resources for the existing reinsurance program and other Exchange priorities. The bill explicitly requires the Exchange to consider market stability, Medicaid and small-group enrollment uncertainty, and the need to keep reinsurance funded through 2028 when setting subsidy levels. Another potential point of contention is the bill’s contingency on federal action, which means the program only activates under a specific and potentially disputed assessment of premium impacts.